Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Amyloid Beta Protein”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT00500500
What this trial is testing

Effect of EGb 761® on Patients With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Ipsen 40
Testing effectiveness (Phase 2)UnknownNCT04174287
What this trial is testing

Modeling the Relationships Between Functional Connectivity and Amyloid Deposition in Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Chang Gung Memorial Hospital 300
Early research (Phase 1)Study completedNCT03522129
What this trial is testing

Study to Evaluate the Effect of CT1812 Treatment on Amyloid Beta Oligomer Displacement Into CSF in Subjects With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Cognition Therapeutics 3
Large-scale testing (Phase 3)Study completedNCT05463731
What this trial is testing

Remternetug (LY3372993) in Participants With Alzheimer's Disease (TRAILRUNNER-ALZ 1)

Who this might be right for
Alzheimer's Disease
Eli Lilly and Company 1,667
Testing effectiveness (Phase 2)Ended earlyNCT00299988
What this trial is testing

Phase II Study of Intravenous Immunoglobulin (IVIg) for Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Weill Medical College of Cornell University 24
Not applicableStudy completedNCT06083233
What this trial is testing

Role of Brain Specific Biomarkers in Hydrocephalus

Who this might be right for
Hydrocephalus, Normal PressureBiochemical Lesions Head RegionBrain Damage
University Hospital Hradec Kralove 32
Not applicableEnded earlyNCT00978536
What this trial is testing

A Monocenter, Cross-sectional Study to Compare Different Type of Cognitive Impairment in Multiple Sclerosis Patients and Cerebrospinal Fluid Biomarkers (Beta Amyloid, Total Tau Protein and Tau-phosphorylated Protein).

Who this might be right for
Disseminated Sclerosis
Nantes University Hospital 29
Not applicableUnknownNCT05002699
What this trial is testing

Investigating the Impact of Alzheimer's Disease Diagnostics in British Columbia

Who this might be right for
Alzheimer DiseaseDementiaCognitive Impairment+1 more
University of British Columbia 120
Testing effectiveness (Phase 2)WithdrawnNCT05728736
What this trial is testing

Acute Effect of Lemborexant on CSF Amyloid-Beta and Tau

Who this might be right for
Alzheimer Disease
Brendan Lucey
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07789873
What this trial is testing

A 28-Day Study of GAL-101 in Participants With Mild to Moderate Alzheimer's Disease

Who this might be right for
Mild to Moderate Alzheimer's Disease
Galimedix Therapeutics Inc 100
Not applicableStudy completedNCT03077620
What this trial is testing

Sleep Quality and Amyloid-Beta Kinetics

Who this might be right for
Amyloid-beta
Washington University School of Medicine 48
Not applicableStudy completedNCT01754168
What this trial is testing

Amyloid Beta and Cognition in Parkinson Disease

Who this might be right for
Parkinson DiseaseNeurological Disorders
University of Michigan 44
Very early researchStudy completedNCT02669225
What this trial is testing

Brain Amyloid- Retention During Wakefulness and Following Emergence From Sleep in Healthy People

Who this might be right for
Normal Physiology
National Institute on Alcohol Abuse and Alcoholism (NIAAA) 22
Testing effectiveness (Phase 2)Looking for participantsNCT06659549
What this trial is testing

Efficacy and Safety Study of GAL-101, 2% Ophthalmic Solution in Non-foveal Geographic Atrophy Secondary to Non-neovascular AMD

Who this might be right for
Geographic Atrophy of the Macula
Galimedix Therapeutics Inc 110
Early research (Phase 1)Ended earlyNCT00968097
What this trial is testing

Evaluation of [123I] MNI-340 and SPECT as a Marker of Beta-Amyloid Protein Deposition

Who this might be right for
Alzheimer's Disease
Institute for Neurodegenerative Disorders 12
Not applicableStudy completedNCT06604390
What this trial is testing

THE EFFECTS OF GAMBIR CATECHIN (UNCARIA GAMBIR ROXB) SUPPLEMENTATION ON COGNITIVE FUNCTION, EXPRESSION OF APP, MAPT, BDNF, IL-10, TGF-Β GENES, AND PLASMA MDA LEVELS IN THE ELDERLY.

Who this might be right for
Elderly Individuals Aged 60 Years or OlderMild Cognitive Impairment (MCI)
Rahmi Novita Yusuf 64
Early research (Phase 1)Study completedNCT00965588
What this trial is testing

Study to Evaluate Safety, Tolerability and Immunogenicity of Vaccine (UB 311) in Subjects With Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
United Biomedical 19
Early research (Phase 1)Study completedNCT00448799
What this trial is testing

Evaluation of [123I] AV83 and SPECT in Patients With Alzheimer Disease in Comparison to Healthy Controls

Who this might be right for
Alzheimers Disease
Molecular NeuroImaging 30
Not applicableStudy completedNCT01982578
What this trial is testing

Genistein as a Possible Treatment for Alzheimer's Disease.

Who this might be right for
Alzheimer's Disease
Fundación para la Investigación del Hospital Clínico de Valencia 27
Not applicableStudy completedNCT01194713
What this trial is testing

Effects of Sleep Deprivation on Cerebrospinal Fluid (CSF) Amyloid-beta (Aβ) Dynamics

Who this might be right for
Alzheimer Disease
University Medical Center Nijmegen 26
Next Page